Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
SpyGlass Pharma, Inc. (SGP) had Weighted-Average Shares Outstanding (Diluted) of 2.22M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
-39.87M |
|
-- |
|
-- |
|
41.45M |
|
-41.45M |
|
1.58M |
|
-39.87M |
|
-39.87M |
|
-39.87M |
|
-39.87M |
|
-39.87M |
|
-39.87M |
|
-41.45M |
|
-40.84M |
|
2.22M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
2.22M |
-17.98 |
|
-17.98 |
|
| Balance Sheet Financials | |
108.77M |
|
2.34M |
|
7.10M |
|
115.87M |
|
8.58M |
|
-- |
|
206.12M |
|
214.70M |
|
-98.84M |
|
-98.84M |
|
-98.84M |
|
2.20M |
|
| Cash Flow Statement Financials | |
-32.70M |
|
-11.79M |
|
124.58M |
|
16.27M |
|
96.36M |
|
80.09M |
|
2.79M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
12.67 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-33.49M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
40.34% |
|
40.34% |
|
-34.41% |
|
40.34% |
|
-44.84 |
|
-15.11 |
|
-14.75 |
|